Nursing home acquired pneumonia

-
Dr Mark Loeb and colleagues at McMaster have published a randomized controlled trial using a clinical pathway for pneumonia in the nursing home. They found that mortality rates , health related quality of life measures and functional outcomes were not significantly different between clinical pathway group and the usual care group. Transfers to hospital, however, were halved in the clinical pathway group ( mean reduction in hospitalize was 12% after adjusting for clustering of residents). They suggest a saving of $1,016 per resident treated

Effect of Clinical Pathway to Reduce hospitalize in Nursing Home Residents With Pneumonia